News

September 11, 2007 - Terumo Interventional Systems announces the launch of its breakthrough Runthrough NS Coronary ...

Home September 10, 2007
Home
28451_1
Feature | Peter Fail, M.D.

More than ever before, cardiologists are adopting CT as the new standard for cardiac care. In the last five years, CT’s popularity as a diagnostic tool has exploded. Its ability to produce slices as thin as 0.5 mm creates a platform for evaluating patients, detecting disease at early stages and designing treatment roadmaps.

Home September 10, 2007
Home
News

September 11, 2007 - CellCyte Genetics Corp. has entered into a collaborative research agreement with physician scientists at the Cleveland Clinic Foundation to investigate the presence and regulation of heart receptors involved in stem cell trafficking in normal and diseased human hearts, using CellCyte's proprietary compounds, with the goal of increasing volumes of stem cells delivered.

Home September 10, 2007
Home
28454_1
Feature | Melissa Allen

New York’s Mount Sinai Heart has it all: a star-studded line-up of internationally renowned physicians, scientists and educators, cutting-edge research and unparalleled clinical services. Their secret to success — an integrated approach to cardiovascular healthcare that makes it all possible.

Home September 10, 2007
Home
News

September 10, 2007 - Signalife launched the sales of its new, FDA-approved, ambulatory 12-lead ECG cardiovascular ...

Home September 09, 2007
Home
28449_1
Feature

iffering approaches for the treatment of coronary bifurcation and ostial lesions (CBOL) continue to feed the debate over which stent designs and stenting techniques are most effective.

Home September 09, 2007
Home
Feature | Cristen C. Bolan

Just when drug-eluting stents (DES) were going to revolutionize interventional cardiology, new reports that DES may be associated with increased risk of late-stent thrombosis have many physicians putting the brakes on DES use. Despite this significant bump in the road, stent manufacturers are forging ahead with clinical trials on novel systems and on plans to roll out new DES platforms in 2008.

Home September 09, 2007
Home
News

September 10, 2007 - Four analyses of three-year follow-up data that were presented at the ESC Congress 2007 showed that ...

Home September 09, 2007
Home
News

September 7, 2007 - Gary Ansel, M.D., Riverside Methodist Hospital, successfully implanted the GORE VIABAHN ...

Home September 09, 2007
Home
28448_1
Feature | Melissa Allen

According to the Centers for Disease Control and Prevention, more than 70 million Americans currently live with ...

Home September 09, 2007
Home
News

September 6, 2007 — ProSolv CardioVascular, a FUJIFILM company (ProSolv), announced at the 12th Annual Scientific ...

Home September 09, 2007
Home
Technology

Sony Electronics recently introduced its LMD-2450MD 24-inch monitor, which offers 10-bit signal processing and Sony ...

Home September 06, 2007
Home
Technology

Possis Medical Inc. will feature the newest advancements in its “Complete Solution for Thrombus,” including the AngioJet Ultra Thrombectomy System, AngioJet Spiroflex and Spiroflex VG catheters and its Fetch Aspiration Catheter.

Home September 06, 2007
Home
Technology

Combining all features of the ACIST CMS and Voyager systems onto one platform, the ACIST CVi Contrast Delivery System ...

Home September 06, 2007
Home
Technology

Guerbet’s flagship X-ray contrast agent, Oxilan (ioxilan) injection, is a contrast agent that is a nonionic, low-viscous ...

Home September 05, 2007
Home
Subscribe Now